News

Added feature offers cost savings and the ability to reduce carbon footprint, company says.

CRO commits to achieving Net-Zero Standard by 2035.

Aims to advance innovative treatments for rare diseases.

Companies to collaborate on facilitating clinical trials in historically underserved regions.

Study focused on the impact of several socioeconomic factors, such as insurance coverage and patients' willingness to travel.

Patient organizations gave $22 billion in grants for research, patient services, and access to care over the last five years, says report.

Since the inception of their partnership in 2008, Medidata and the NCI have collaborated across thousands of clinical trials.

Pharma company is the second to join the project.

New module designed to provide simple storage of participant consent.

GenosAI, embedded into H1's clinical trial intelligence platform, Trial Landscape, can analyze and respond to complex inquiries.

Developed with industry stakeholders, Longboat v2.2 provides patients with access to their study information in one site-focused solution.

Collaboration to focus on accelerating clinical development and increase access to research.

Company intends to expand AI and predictive clinical trial intelligence throughout the Asia-Pacific region.

New clinical research approach aims to accelerate and streamline clinical development for emerging biopharm organizations.

Company can now incorporate affiliates into safety workflows, boost operational efficiencies, ensure compliance, and unify its global pharmacovigilance data on one platform.

Ronco is a global pharmaceutical executive with experience in a number of R&D leadership positions over more than two decades.

Bingham discusses the logistical challenges associated with coordinating patient involvement in rare disease clinical trials.

Agency is announcing the opportunity for a limited number of sponsors to participate in a pilot program allowing for more frequent communication with FDA staff.

With support from LabCorp, partnership aims to bring trials to patients in south central Kentucky.

Joint venture aims to drive new discoveries and improve patient outcomes.

Strategic collaboration aims to drive diversity and inclusion within the realm of clinical trials.

Platform enables management of high-frequency sensor data with security.

Exploring the implications of FDA’s renewed focus and commitment to expand the use of accelerated approval for gene therapy products.

Joint venture aims to streamline handling of tissue and samples and subsequent digitization in support of clinical trial endpoint generation.

Scheduled visits can become virtual with video calls augmented directly through the platform and patients signing in through their existing participant portal.

Platform includes an expanded global library.

Legislative efforts seek a common framework in accessing and applying real-world data and evidence in clinical studies.

Company expected to research patient engagement, response durability, and health economics of new medical device.